Search research articles
Contact Us
Filters
Showing results (201-210 of 257) with videos related to
Page
of 26
Sort By:
Cancers
|
September 27, 2025
Application of the STRATCANS Criteria to the MUSIC Prostate Cancer Active Surveillance Cohort: A Step Towards Risk-Stratified Active Surveillance
Ana M Moser, Michael Wang, Ava Zamani, et al.
European Urology Focus
|
November 15, 2018
Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study
Brian R Lane, Stephen K Babitz, Katerina Vlasakova, et al.
The Journal of Urology
|
April 9, 2024
Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity
Yuzhi Wang, Samantha Wilder, Mohit Butaney, et al.
European Urology Focus
|
July 20, 2020
Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort
Jacob Taylor, Ezequiel Becher, James S Wysock, et al.
The Journal of Urology
|
March 22, 2023
Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY Analysis
Mohit Butaney, Samantha Wilder, Amit K Patel, et al.
Urologic Oncology
|
November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses
Michael Wang, Aaron Wilke, Samuel Goorman, et al.
European Urology Oncology
|
June 4, 2021
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited
Umberto Capitanio, Riccardo Autorino, Marco Bandini, et al.
Urology
|
May 2, 2021
Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative
Roshan Paudel, Stephanie Ferrante, Ji Qi, et al.
European Urology Open Science
|
December 4, 2025
Outcomes After Initial Noninterventional Management of Clinical Stage cT1b Renal Masses
Banna Hussain, Jack Considine, Yuzhi Wang, et al.
Urologic Oncology
|
May 9, 2025
Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer Database
Dhruv Puri, Brian R Lane, Natalie Birouty, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 257) with videos related to
Sort By:
Page
of 26
Cancers
|
September 27, 2025
Application of the STRATCANS Criteria to the MUSIC Prostate Cancer Active Surveillance Cohort: A Step Towards Risk-Stratified Active Surveillance
Ana M Moser, Michael Wang, Ava Zamani, et al.
European Urology Focus
|
November 15, 2018
Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study
Brian R Lane, Stephen K Babitz, Katerina Vlasakova, et al.
The Journal of Urology
|
April 9, 2024
Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity
Yuzhi Wang, Samantha Wilder, Mohit Butaney, et al.
European Urology Focus
|
July 20, 2020
Primary Robot-assisted Retroperitoneal Lymph Node Dissection for Men with Nonseminomatous Germ Cell Tumor: Experience from a Multi-institutional Cohort
Jacob Taylor, Ezequiel Becher, James S Wysock, et al.
The Journal of Urology
|
March 22, 2023
Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY Analysis
Mohit Butaney, Samantha Wilder, Amit K Patel, et al.
Urologic Oncology
|
November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal masses
Michael Wang, Aaron Wilke, Samuel Goorman, et al.
European Urology Oncology
|
June 4, 2021
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited
Umberto Capitanio, Riccardo Autorino, Marco Bandini, et al.
Urology
|
May 2, 2021
Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative
Roshan Paudel, Stephanie Ferrante, Ji Qi, et al.
European Urology Open Science
|
December 4, 2025
Outcomes After Initial Noninterventional Management of Clinical Stage cT1b Renal Masses
Banna Hussain, Jack Considine, Yuzhi Wang, et al.
Urologic Oncology
|
May 9, 2025
Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer Database
Dhruv Puri, Brian R Lane, Natalie Birouty, et al.
Page
of 26